ResMed has grown into a company that specialises in non-invasive technology solutions that improve sleep health worldwide.

The company reported fiscal second quarter results, highlighting the establishment of a new OSA Clinical Advisory Board with Dr. Alison Wimms from ResMed ... including CPAP, with the Phase ...

Positive IHL-42X PK findings for the treatment of Obstructive Sleep Apnea (OSA) support future 505(b)(2) New Drug Application (NDA) submission New OSA Clinical Advisory Board Announced; Appoints Dr.

ResMed's EPS and revenue exceeded forecasts for Q2 FY2025. Stock price declined 6.6% in after-hours trading despite strong earnings. ResMed launched new products and expanded its digital health ...

Treating sleep apnea with a continuous positive airway pressure (CPAP) machine may help reduce arrhythmias by improving your oxygen supply while you sleep. This device helps keep your airways from ...

Learn More The ResMed Inc (ASX: RMD) share price is under pressure on Monday. In morning trade, the sleep disorder treatment company's shares are down over 4% to $38.35. Investors have been ...

ResMed Inc. (NYSE:RMD ... Brightree for home medical equipment players, as well as for patients, the myAir app, they continue together to power these ReSupply programs. We are actively investing ...

Investing.com -- Shares of ResMed (NYSE:RMD) fell 6% today, despite the company reporting second-quarter earnings that surpassed analyst expectations. The medical equipment maker posted earnings ...

ResMed Inc (ASX: RMD) shares are rising on Friday morning. At the time of writing, the sleep disorder treatment company's shares are up 0.5% to $40.70. This follows the release of the company's ...

Have you been paying attention to shares of ResMed (RMD)? Shares have been on the move with the stock up 12.8% over the past month. The stock hit a new 52-week high of $263.05 in the previous session.